Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine. The Company develops, manufactures, and commercialises a range of molecular assays and instrumentation to deliver workflows and services that enable seamless end-to-end solutions from sample to result across multiple sectors including human health, animal health and environmental.
The Company is divided into three business segments:
Clinical: a broad portfolio of human clinical in vitro diagnostic products, workflows and services focused on three therapeutic areas:
Reproductive Health: NIPT, Cystic Fibrosis and other rapid aneuploidy tests
Precision Medicine: DPYD genotyping assay
Infectious Diseases: Winterplex, multiplex winter respiratory PCR panel
Instrumentation: a portfolio of next generation size selection DNA sample preparation platforms and rapid PCR machines, including:
Ranger® Technology: automated DNA sample preparation and target enrichment technology
genesig q16 and q32 real-time quantitative PCR (qPCR) instruments
Research Use Only: range of assays and services for the life science industry:
Design, manufacture, and supply of high-performance qPCR assays and workflows for use in human health, agriculture, veterinary and environmental, to support global health organisations and the research industry
Pharmaceutical research services: whole genome sequencing (WGS) / whole exome sequencing (WES)
Novacyt is headquartered in Vélizy in France with offices in the UK (in Eastleigh and Manchester), Singapore, the US and Canada and has a commercial presence in over 65 countries. The Company is listed on the London Stock Exchange’s AIM market (“NCYT”) and on the Paris Stock Exchange Euronext Growth (“ALNOV”).
Primer Design is a pioneering molecular diagnostic company. Our mission is to enable our customers to improve health outcomes, ensuring Food Safety & Integrity of Supply Chain and enhance the well-being of pets, animals and livestock by providing an extensive portfolio of qPCR products and delivering custom development services and solutions.
Primer Design is focused on the design, manufacture, validation and supply of real-time PCR kits and reagents. The company was founded in 2005 within Southampton University's School of Medicine. Since that humble beginning, the company has gone from strength to strength – thousands of customers in over 100 countries around the World and a fantastic reputation in the field.
Yourgene Health has a comprehensive offering of non-invasive prenatal tests (NIPT) NGS workflows that have been built with labs in mind, and clinical prenatal screening services
Continuing to build on our expertise in cell-free DNA, our next generation size selection Ranger® Technology uses machine vision for superior precision. With multiple platforms for a range of clinical and research cfDNA sample preparation applications including NIPT, liquid biopsy, oncology, gene synthesis and long fragment recovery.
Yourgene also offer a portfolio of PCR assays for Reproductive Health and Precision Medicine.
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
For Careers information for the Novacyt Group, please click the link button below to view our vacancies.
